Editas Medicine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
EDIT Key Statistics
Stock Snapshot
Editas Medicine(EDIT) stock is priced at $3.44, giving the company a market capitalization of 336.8M. It carries a P/E multiple of -2.83.
During the trading session on 2026-05-31, Editas Medicine(EDIT) shares reached a daily high of $3.51 and a low of $3.24. At a current price of $3.44, the stock is +6.2% higher than the low and still -2.0% under the high.
Trading activity shows a volume of 3.91M, compared to an average daily volume of 4.24M.
The stock's 52-week range extends from a low of $1.66 to a high of $4.54.
The stock's 52-week range extends from a low of $1.66 to a high of $4.54.
EDIT News
After Editas Medicine (EDIT) presented new preclinical data for EDIT-401, its lead in vivo development candidate, in an oral presentation at the European Athero...
Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Editas Medicine (EDIT) presented new preclinical data for EDIT-401, its lead in vivo development candidate, in an oral presentation at the 94th European Atheros...
Analyst ratings
62%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.